top of page

CHO-K1/Rat CCK2 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0076C

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The Cholecystokinin B receptor (CCK2 or CCK-B) is a G protein-coupled receptor with high affinity for both cholecystokinin and gastrin. It is widely expressed in the central nervous system (e.g., cerebral cortex, limbic system) and the gastrointestinal tract (e.g., gastric parietal cells, certain intestinal cells). Its primary functions involve mediating neuromodulatory effects in the CNS, regulating anxiety, pain perception, memory, and dopaminergic neuron activity. Peripherally, it potently stimulates gastric acid secretion from parietal cells and may influence cell proliferation. Consequently, the CCK2 receptor is a significant therapeutic target for anxiety disorders, analgesia, and gastric acid-related conditions such as gastrinoma.

 

Screeningbio’s CHO-K1/Rat CCK2 cell line overexpress CCK2 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Rat

HGNC Symbol

CCK2

Accession Number

NM_013165

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Rat CCK2 Agonist Assay. CHO-K1/Rat CCK2 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Rat CCK2 Agonist Assay. CHO-K1/Rat CCK2 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


The Cholecystokinin B receptor (CCK2 or CCK-B) is a G protein-coupled receptor with high affinity for both cholecystokinin and gastrin. It is widely expressed in the central nervous system (e.g., cerebral cortex, limbic system) and the gastrointestinal tract (e.g., gastric parietal cells, certain intestinal cells).


Its primary functions involve mediating neuromodulatory effects in the CNS, regulating anxiety, pain perception, memory, and dopaminergic neuron activity. Peripherally, it potently stimulates gastric acid secretion from parietal cells and may influence cell proliferation. Consequently, the CCK2 receptor is a significant therapeutic target for anxiety disorders, analgesia, and gastric acid-related conditions such as gastrinoma.

 

Product Documentation



bottom of page